We are live on ! Find out more
ZYME icon

Zymeworks

15 hedge funds and large institutions have $13.7M invested in Zymeworks in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

25% more funds holding

Funds holding: 1215 (+3)

0.02% less ownership

Funds ownership: 7.31%7.29% (-0.02%)

7% less capital invested

Capital invested by funds: $14.8M → $13.7M (-$1.07M)

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
4
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change

ZYME Hedge Fund Activity: Q4 2017 in Review

15 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q4 2017, worth a combined $13.7M — down 7.3% from $14.8M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ZYME positions and 3 closed out — a net gain of 3 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $384K. The largest seller was Royal Bank of Canada, cutting an estimated $461K.

  • 15 institutional investors held Zymeworks (ZYME) as of Q4 2017, up from 12 in Q3 2017.
  • Funds reported $13.7M of Zymeworks stock for Q4 2017, down 7.3% quarter-over-quarter.
  • 6 funds opened new Zymeworks positions in Q4 2017 and 3 closed out, a net change of +3 holders.
  • The largest Zymeworks buyer in Q4 2017 was Perceptive Advisors, an estimated $384K added.
  • The largest Zymeworks seller in Q4 2017 was Royal Bank of Canada, an estimated $461K sold.

Based on aggregated 13F filings for Q4 2017.